BioDuro-Sundia’s Post

#Takeaways: How does X-Chem facilitate covalent drug discovery for partners? The identification of novel covalent ligands for therapeutic purposes has long depended on serendipity. At X-Chem, we design highly efficient methods to identify new chemical equity towards targets of interest, aiming to improve the safety, potency, and selectivity of the outcome. You can learn more in our covalent drug discovery webinar: https://lnkd.in/gSa6pPw4 Selected success examples: - Bfl1 reversible inhibitor: https://lnkd.in/eZsxQPmr - WDR91 inhibitor: https://lnkd.in/eJihD4bn - BTK inhibitors: https://lnkd.in/dDeUYkj #DrugDiscovery #CovalentDrug #HitID #LeadOptimization #Pharma #Biotech #DrugDevelopment #Technology

Bellen is committed to continued investment in both capabilities and capacity to enable an open access and integrated one-stop-shop chemistry platform, thereby, adding value to your research and development of new drug discovery programs. #CRO #CDMO #FTE #API #chemistryservices #pharma #medicinalchemistry #drugdiscovery #preclinicalresearch #processdevelopment #bellenchem #customsynthesis #smallmolecules #intermediates

NOW ON-DEMAND: “Organoid Meets Microelectrode Array (MEA) – Accelerating Drug Discovery and Development” Sven Schönecker, PhD, and Sara Mirsadeghi, MSc, discuss new developments and applications of 3D Mesh Microelectrode Arrays (MEA). Watch it here ⏩ https://bit.ly/3ry2CLT #DrugDiscovery #DrugDevelopment #Pharma #PharmaWebinar

The novelty, complexity and evolving regulatory guidance of oligonucleotide (oligo) therapies can create greater technical challenges for drug development than conventional drugs, but the right laboratory partner and technology can alleviate those challenges. Learn how to tackle the challenges of metabolite profiling and identification for oligo drug development. #MetID #oligonucleotide #Drugdevelopment https://hubs.li/Q027Lfkm0

Live from the lab! Such a treat to listen in on the results of scientists putting our instruments to good use. From drug discovery with our Astral mass spectrometer to clinical validation with our new Stellar mass spectrometer. Taking steps towards the dream of individualized pharmaceuticals and in-depth understanding of API interaction with metabolite regulation and our proteome. #thermofisherscientific #stellarmasspectrometer #proteomics

The novelty, complexity and evolving regulatory guidance of oligonucleotide (oligo) therapies can create greater technical challenges for drug development than conventional drugs, but the right laboratory partner and technology can alleviate those challenges. Learn how to tackle the challenges of metabolite profiling and identification for oligo drug development. #MetID #oligonucleotide #Drugdevelopment https://hubs.li/Q027Lw-m0

The webinar is starting in 1 hour! Peptides are fast gaining traction in 2024, with #Semaglutide and #Tirzepatide at the top of the list! Both in today's pharma industry and in popular culture, these two peptides are hugely in demand. Now is the time for you to jump on the bandwagon to source these and other peptide APIs. It's not too late to sign up 👉 https://ow.ly/9ijb50QIHhf

Dear #Linkedinfamily Stay informed with the latest updates! Catch our news bulletin for breaking news, in-depth analysis, and exclusive stories. Follow us to stay ahead and never miss out on important news. Centaur Pharma launches new generic cardiac drug ivabradine hydrochloride in US Click the Link Below for More & Detailed Info: https://lnkd.in/gmGBp-FQ Follow us for real-time updates and in-depth analysis. Lifescience Intellipedia Pvt. Ltd. Chemxpert Database #lifescienceintellipedia #lifesciences #chemxpert #chemxpertdatabase #database #daily #new #PharmaNews #PharmaUpdates #BiotechNews #PharmaInnovation #PharmaResearch #MedicalResearch #PharmaIndustry #NewMedication #PharmaTrends #Biopharma #PharmaTech

Dear #Linkedinfamily Stay informed with the latest updates! Catch our news bulletin for breaking news, in-depth analysis, and exclusive stories. Follow us to stay ahead and never miss out on important news. Centaur Pharma launches new generic cardiac drug ivabradine hydrochloride in US Click the Link Below for More & Detailed Info: https://lnkd.in/gmGBp-FQ Follow us for real-time updates and in-depth analysis. Lifescience Intellipedia Pvt. Ltd. Chemxpert Database #lifescienceintellipedia #lifesciences #chemxpert #chemxpertdatabase #database #daily #new #PharmaNews #PharmaUpdates #BiotechNews #PharmaInnovation #PharmaResearch #MedicalResearch #PharmaIndustry #NewMedication #PharmaTrends #Biopharma #PharmaTech

This week's Pearce IP #BioBlast features the following (and more!): - #omalizumab: Celltrion Inc submits BLA for interchangeable #omalizumab (#Xolair®) biosimilar - #omalizumab: CuraTeQ Biologics’ #omalizumab biosimilar (#BP11) Phase I completion - #pembrolizumab: A second challenge commenced by Merck (this time IPR) against four Johns Hopkins #pembrolizumab MOT patents - #ranibizumab: Formycon AG / MS PHARMA’s #ranibizumab biosimilar (#Ravegza®) approved in Saudi Arabia - #adalimumab / #semaglutide / #teriparatide: AU's November 2023 PBAC public summary documents feature biopharma developments Read more: https://lnkd.in/gZ_sxhrm   #bioblast #biosimilars #boutiquelawfirm #australia #patentlaw #awardwinning #pearceip #patents #biopharma #lifesciences #femalefounder